Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Payers
New study finds 137M US adults are eligible for GLP-1s
Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would benefit from the drugs.
Paige Minemyer
Nov 25, 2024 4:00pm
Payer Roundup—Gov. Newsom vetoes PBM, private equity bills
Sep 30, 2024 2:40pm
Telehealth company Ro rolls out GLP-1 supply tracker
May 30, 2024 2:00pm
Costco, Sesame expand into weight loss management
Apr 2, 2024 2:00pm
Payer Roundup—UHG renewable energy plan; BSC for a safer Oakland
Mar 29, 2024 3:31pm
WeightWatchers rolls out telehealth clinic with GLP-1s
Dec 18, 2023 1:00pm
